| Transaction Date | Filer | Title | Filing | Transaction Type | Shares Traded | Price | Total Held* |
|---|---|---|---|---|---|---|---|
| May 17, 2023 | Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 392 | $447.34 | 461 | |
| May 05, 2023 | CVP & Chief Financial Officer | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 3,847 | -- | 10,652 | |
| May 05, 2023 | CVP & Chief Financial Officer | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 1,736 | $446.81 | 8,916 | |
| May 05, 2023 | CVP & Chief Financial Officer | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 3,847 | -- | 8,191 | |
| May 04, 2023 | CVP, Global Operations | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 2,720 | -- | 2,720 | |
| May 04, 2023 | CVP, Global Operations | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 1,135 | $442.23 | 1,585 | |
| May 04, 2023 | CVP, Global Operations | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 2,720 | -- | 5,377 | |
| Mar 31, 2023 | Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 97 | $461.72 | 8,345 | |
| Mar 31, 2023 | Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 76 | $461.72 | 23,942 | |
| Mar 31, 2023 | Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 76 | $461.72 | 252 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.